1 Min Read
Feb 19 (Reuters) - MOLECULAR PARTNERS AG:
* MOLECULAR PARTNERS’ PARTNER ALLERGAN EXERCISES THIRD OPTION FOR DARPIN PRODUCT CANDIDATE IN OPHTHALMOLOGY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.